EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease

Andrea Ott, Erol Tutdibi iD, Sybelle Goedicke-Fritz, Jakob Schöpe, Michael Zemlin, Nasenien Nourkami-Tutdibi iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0288147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Andrea Ott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for General Pediatrics and Neonatology, Saarland University Medical Center, Homburg/Saar, Germany. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel diseases (IBDs) with the subtypes ulcerative colitis (UC) and Crohn disease (CD), are chronic autoimmune inflammatory disorders of the gastrointestinal tract. Cytokines are associated with the development and progression in pediatric IBD. We measured cytokine levels in pediatric IBD patients to assess their potential function as biomarkers in disease assessment.

Method

In this prospective cohort study, we enrolled 33 children with IBD. All patients were in stable remission for 3 months on enrollment. Patients who developed a relapse within six months after enrollment were classified as relapsers. Blood sampling was performed at enrolment and for relapsers in relapse and post-relapse. Serum concentrations of 14 cytokines, chemokines and growth factors (IL-1α, IL-1β, IL-6, IL-12p40, IP-10, TNF-α, IFN-γ, IL-10, IL-8, MIP-1α, MCP-1, MCP-3, G-CSF, GM-CSF) were measured simultaneously using multiplex bead-based sandwich immunoassay on Luminex 100 system.

Results

MCP-1 was significantly higher in CD patients compared to UC patients at each disease stage: stable remission (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesChildHumansBiomarkersCytokinesGranulocyte Colony-Stimulating FactorProspective StudiesRecurrenceChemokine CCL2

Substanzen

BiomarkersCytokinesGranulocyte Colony-Stimulating FactorCCL2 protein, humanChemokine CCL2

Autor:innen und Institutionen

  • Hospital for General Pediatrics and Neonatology, Saarland University Medical Center, Homburg/Saar, Germany.
  • Institute of Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg/Saar, Germany.

ORCID-Profile: Erol Tutdibi, Nasenien Nourkami-Tutdibi

Zitieren

APA

Ott, A., Tutdibi, E., Goedicke-Fritz, S., Schöpe, J., Zemlin, M., & Nourkami-Tutdibi, N. (2023). Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0288147

Vancouver

Ott A, Tutdibi E, Goedicke-Fritz S, Schöpe J, Zemlin M, Nourkami-Tutdibi N. Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease. PLOS ONE. 2023. doi:10.1371/journal.pone.0288147

BibTeX
@article{Ott2023,
  author = {Ott, Andrea and Tutdibi, Erol and Goedicke-Fritz, Sybelle and Schöpe, Jakob and Zemlin, Michael and Nourkami-Tutdibi, Nasenien},
  title = {Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0288147}
}
Kostenlos starten →